Aldatu Biosciences Inc

BioSensics LLC is a global leader in the development of wearable sensors and digital platforms for clinical trials, patient monitoring, and health assessment, offering advanced technologies for effective measurement and analysis of digital biomarkers and health data. With their turnkey products, including wearable sensors, mobile health applications, and medical devices, BioSensics revolutionizes clinical trials and research, patient monitoring, and health assessment, providing comprehensive operational and technical services for these purposes.Generated from the website

Skygenic Inc, based in Watertown, MA, offers a cloud-based platform designed for the storage and analysis of genomic data, enabling researchers to manage their data efficiently without the need for programming skills or dedicated bioinformaticians. With features such as seamless data compression and an intuitive organizational system, Skygenic aims to enhance collaboration and streamline research processes for scientific advancement. Skygenic focuses on providing HIPAA-compliant solutions that allow for the storage, sharing, and analysis of large data sets, emphasizing user-friendly tools that prioritize transparency and efficiency. The platform boasts significant cost savings through high levels of data compression, enabling researchers to maximize their time on impactful scientific work rather than data management. Generated from the website

MelliCell Inc. is a biotechnology company based in Watertown, MA, specializing in pioneering adipocyte therapies for chronic diseases through innovative fat cell engineering technology. Their mission is to harness the potential of mature human fat cells to develop therapeutic solutions aimed at improving the health and lives of individuals suffering from conditions such as diabetes and obesity. With a commitment to integrity, respect, and collaboration, MelliCell partners with leading biomedical organizations like Mass General Brigham to advance their research initiatives. Recently awarded a prestigious SEED grant from the National Institutes of Health, the company is poised to accelerate the development of novel biologic drugs and therapeutic approaches that address the growing global health challenges associated with chronic diseases. Generated from the website